Multiple mechanisms that include but are not limited to TGF-β signaling have been associated with aberrant EndMT in different CVDs like coronary artery disease (CAD) or peripheral artery disease-induced atherosclerosis [392], MI [393,394], and valvular heart diseases like mitral valve prolapse [395]. This evidence concerns the gene TGFB1 and coronary artery disorder.